Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials
暂无分享,去创建一个
S. Siler | T. Parry | B. Howell | Grant T. Generaux | J. Iaci | A. Eisen | A. Caggiano | M. Mosedale | D. Longo | G. Generaux | B. Howell | S. Siler | D. Antoine | D. Button | R. Stanulis | P. Watkins | Paul B. Watkins | Diane M. Longo | Daniel J. Antoine | Donald Button | Andrew Eisen | Tom J. Parry | D. J. Antoine